CHOLESTECH LDX ASPARTATE AMINOTRANSFERASE (AST)— 510(k) K032027
Substantially EquivalentCholestech Corp.
FDA 510(k) clearance K032027 for CHOLESTECH LDX ASPARTATE AMINOTRANSFERASE (AST), Substantially Equivalent on 2003-09-05. Applicant: Cholestech Corp.. Device class: 2.
Clearance details
- Applicant
- Cholestech Corp.
- Product code
- Code CIS
- Device class
- Class 2
- Regulation
- 21 CFR 862.1100
- Advisory panel
- Clinical Chemistry
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Hayward, CA, US
Recent devices under product code CIS
view allMore clearances from Cholestech Corp.
view allRecalls naming K032027
K-number listed on FDA's recall recordMatched by K-number from FDA's Recall Enterprise System record (openFDA device/recallk_numbers) — these recalls explicitly list K032027.
Data sourced from openFDA. This site is unofficial and independent of the FDA.